1 Study Coverage 1.1 Asthma Preventive Product Introduction 1.2 Global Asthma Preventive Outlook 2017 VS 2022 VS 2028 1.2.1 Global Asthma Preventive Sales in US$ Million for the Year 2017-2028 1.2.2 Global Asthma Preventive Sales in Volume for the Year 2017-2028 1.3 United States Asthma Preventive Outlook 2017 VS 2022 VS 2028 1.3.1 United States Asthma Preventive Sales in US$ Million for the Year 2017-2028 1.3.2 United States Asthma Preventive Sales in Volume for the Year 2017-2028 1.4 Asthma Preventive Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Asthma Preventive in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Asthma Preventive Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Asthma Preventive Market Dynamics 1.5.1 Asthma Preventive Industry Trends 1.5.2 Asthma Preventive Market Drivers 1.5.3 Asthma Preventive Market Challenges 1.5.4 Asthma Preventive Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Asthma Preventive Market Segment by Type 2.1.1 Sodium Cromolyn 2.1.2 Prednisolone 2.2 Global Asthma Preventive Market Size by Type 2.2.1 Global Asthma Preventive Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Asthma Preventive Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Asthma Preventive Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Asthma Preventive Market Size by Type 2.3.1 United States Asthma Preventive Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Asthma Preventive Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Asthma Preventive Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Asthma Preventive Market Segment by Application 3.1.1 Children 3.1.2 Adult 3.2 Global Asthma Preventive Market Size by Application 3.2.1 Global Asthma Preventive Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Asthma Preventive Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Asthma Preventive Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Asthma Preventive Market Size by Application 3.3.1 United States Asthma Preventive Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Asthma Preventive Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Asthma Preventive Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Asthma Preventive Competitor Landscape by Company 4.1 Global Asthma Preventive Market Size by Company 4.1.1 Top Global Asthma Preventive Manufacturers Ranked by Revenue (2021) 4.1.2 Global Asthma Preventive Revenue by Manufacturer (2017-2022) 4.1.3 Global Asthma Preventive Sales by Manufacturer (2017-2022) 4.1.4 Global Asthma Preventive Price by Manufacturer (2017-2022) 4.2 Global Asthma Preventive Concentration Ratio (CR) 4.2.1 Asthma Preventive Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Asthma Preventive in 2021 4.2.3 Global Asthma Preventive Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Asthma Preventive Manufacturing Base Distribution, Product Type 4.3.1 Global Asthma Preventive Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Asthma Preventive Product Type 4.3.3 Date of International Manufacturers Enter into Asthma Preventive Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Asthma Preventive Market Size by Company 4.5.1 Top Asthma Preventive Players in United States, Ranked by Revenue (2021) 4.5.2 United States Asthma Preventive Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Asthma Preventive Sales by Players (2020, 2021 & 2022) 5 Global Asthma Preventive Market Size by Region 5.1 Global Asthma Preventive Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Asthma Preventive Market Size in Volume by Region (2017-2028) 5.2.1 Global Asthma Preventive Sales in Volume by Region: 2017-2022 5.2.2 Global Asthma Preventive Sales in Volume Forecast by Region (2023-2028) 5.3 Global Asthma Preventive Market Size in Value by Region (2017-2028) 5.3.1 Global Asthma Preventive Sales in Value by Region: 2017-2022 5.3.2 Global Asthma Preventive Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Asthma Preventive Market Size YoY Growth 2017-2028 6.1.2 North America Asthma Preventive Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Asthma Preventive Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Asthma Preventive Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Asthma Preventive Market Size YoY Growth 2017-2028 6.3.2 Europe Asthma Preventive Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Asthma Preventive Market Size YoY Growth 2017-2028 6.4.2 Latin America Asthma Preventive Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Asthma Preventive Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Asthma Preventive Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Pfizer 7.1.1 Pfizer Corporation Information 7.1.2 Pfizer Description and Business Overview 7.1.3 Pfizer Asthma Preventive Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Pfizer Asthma Preventive Products Offered 7.1.5 Pfizer Recent Development 7.2 Abbot 7.2.1 Abbot Corporation Information 7.2.2 Abbot Description and Business Overview 7.2.3 Abbot Asthma Preventive Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Abbot Asthma Preventive Products Offered 7.2.5 Abbot Recent Development 7.3 Novartis 7.3.1 Novartis Corporation Information 7.3.2 Novartis Description and Business Overview 7.3.3 Novartis Asthma Preventive Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Novartis Asthma Preventive Products Offered 7.3.5 Novartis Recent Development 7.4 Roche 7.4.1 Roche Corporation Information 7.4.2 Roche Description and Business Overview 7.4.3 Roche Asthma Preventive Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Roche Asthma Preventive Products Offered 7.4.5 Roche Recent Development 7.5 GSK 7.5.1 GSK Corporation Information 7.5.2 GSK Description and Business Overview 7.5.3 GSK Asthma Preventive Sales, Revenue and Gross Margin (2017-2022) 7.5.4 GSK Asthma Preventive Products Offered 7.5.5 GSK Recent Development 7.6 Merck 7.6.1 Merck Corporation Information 7.6.2 Merck Description and Business Overview 7.6.3 Merck Asthma Preventive Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Merck Asthma Preventive Products Offered 7.6.5 Merck Recent Development 7.7 Astrazeneca 7.7.1 Astrazeneca Corporation Information 7.7.2 Astrazeneca Description and Business Overview 7.7.3 Astrazeneca Asthma Preventive Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Astrazeneca Asthma Preventive Products Offered 7.7.5 Astrazeneca Recent Development 7.8 Biotest AG 7.8.1 Biotest AG Corporation Information 7.8.2 Biotest AG Description and Business Overview 7.8.3 Biotest AG Asthma Preventive Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Biotest AG Asthma Preventive Products Offered 7.8.5 Biotest AG Recent Development 7.9 Boehringer Ingelheim 7.9.1 Boehringer Ingelheim Corporation Information 7.9.2 Boehringer Ingelheim Description and Business Overview 7.9.3 Boehringer Ingelheim Asthma Preventive Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Boehringer Ingelheim Asthma Preventive Products Offered 7.9.5 Boehringer Ingelheim Recent Development 7.10 Chiesi 7.10.1 Chiesi Corporation Information 7.10.2 Chiesi Description and Business Overview 7.10.3 Chiesi Asthma Preventive Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Chiesi Asthma Preventive Products Offered 7.10.5 Chiesi Recent Development 7.11 Sumitomo Dainippon Pharma 7.11.1 Sumitomo Dainippon Pharma Corporation Information 7.11.2 Sumitomo Dainippon Pharma Description and Business Overview 7.11.3 Sumitomo Dainippon Pharma Asthma Preventive Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Sumitomo Dainippon Pharma Asthma Preventive Products Offered 7.11.5 Sumitomo Dainippon Pharma Recent Development 7.12 Amgen 7.12.1 Amgen Corporation Information 7.12.2 Amgen Description and Business Overview 7.12.3 Amgen Asthma Preventive Sales, Revenue and Gross Margin (2017-2022) 7.12.4 Amgen Products Offered 7.12.5 Amgen Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Asthma Preventive Industry Chain Analysis 8.2 Asthma Preventive Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Asthma Preventive Distributors 8.3 Asthma Preventive Production Mode & Process 8.4 Asthma Preventive Sales and Marketing 8.4.1 Asthma Preventive Sales Channels 8.4.2 Asthma Preventive Distributors 8.5 Asthma Preventive Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Asthma Preventive CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Asthma Preventive Market Trends Table 3. Asthma Preventive Market Drivers Table 4. Asthma Preventive Market Challenges Table 5. Asthma Preventive Market Restraints Table 6. Global Asthma Preventive Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Asthma Preventive Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Asthma Preventive Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Asthma Preventive Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Asthma Preventive Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Asthma Preventive Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Asthma Preventive Revenue Share by Manufacturer, 2017-2022 Table 13. Global Asthma Preventive Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Asthma Preventive Sales Share by Manufacturer, 2017-2022 Table 15. Global Asthma Preventive Price by Manufacturer (2017-2022) & (USD/Unit) Table 16. Global Asthma Preventive Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Asthma Preventive by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Preventive as of 2021) Table 18. Top Players of Asthma Preventive in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Asthma Preventive Product Type Table 20. Date of International Manufacturers Enter into Asthma Preventive Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Asthma Preventive Players in United States Market, Ranking by Revenue (2021) Table 23. United States Asthma Preventive Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Asthma Preventive Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Asthma Preventive Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Asthma Preventive Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Asthma Preventive Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Asthma Preventive Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Asthma Preventive Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Asthma Preventive Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Asthma Preventive Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Asthma Preventive Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Asthma Preventive Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Asthma Preventive Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Asthma Preventive Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Asthma Preventive Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Asthma Preventive Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Asthma Preventive Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Asthma Preventive Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Asthma Preventive Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Asthma Preventive Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Pfizer Corporation Information Table 43. Pfizer Description and Business Overview Table 44. Pfizer Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 45. Pfizer Asthma Preventive Product Table 46. Pfizer Recent Development Table 47. Abbot Corporation Information Table 48. Abbot Description and Business Overview Table 49. Abbot Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 50. Abbot Product Table 51. Abbot Recent Development Table 52. Novartis Corporation Information Table 53. Novartis Description and Business Overview Table 54. Novartis Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 55. Novartis Product Table 56. Novartis Recent Development Table 57. Roche Corporation Information Table 58. Roche Description and Business Overview Table 59. Roche Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 60. Roche Product Table 61. Roche Recent Development Table 62. GSK Corporation Information Table 63. GSK Description and Business Overview Table 64. GSK Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. GSK Product Table 66. GSK Recent Development Table 67. Merck Corporation Information Table 68. Merck Description and Business Overview Table 69. Merck Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 70. Merck Product Table 71. Merck Recent Development Table 72. Astrazeneca Corporation Information Table 73. Astrazeneca Description and Business Overview Table 74. Astrazeneca Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 75. Astrazeneca Product Table 76. Astrazeneca Recent Development Table 77. Biotest AG Corporation Information Table 78. Biotest AG Description and Business Overview Table 79. Biotest AG Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 80. Biotest AG Product Table 81. Biotest AG Recent Development Table 82. Boehringer Ingelheim Corporation Information Table 83. Boehringer Ingelheim Description and Business Overview Table 84. Boehringer Ingelheim Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 85. Boehringer Ingelheim Product Table 86. Boehringer Ingelheim Recent Development Table 87. Chiesi Corporation Information Table 88. Chiesi Description and Business Overview Table 89. Chiesi Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 90. Chiesi Product Table 91. Chiesi Recent Development Table 92. Sumitomo Dainippon Pharma Corporation Information Table 93. Sumitomo Dainippon Pharma Description and Business Overview Table 94. Sumitomo Dainippon Pharma Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 95. Sumitomo Dainippon Pharma Product Table 96. Sumitomo Dainippon Pharma Recent Development Table 97. Amgen Corporation Information Table 98. Amgen Description and Business Overview Table 99. Amgen Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 100. Amgen Product Table 101. Amgen Recent Development Table 102. Key Raw Materials Lists Table 103. Raw Materials Key Suppliers Lists Table 104. Asthma Preventive Customers List Table 105. Asthma Preventive Distributors List Table 106. Research Programs/Design for This Report Table 107. Key Data Information from Secondary Sources Table 108. Key Data Information from Primary Sources List of Figures Figure 1. Asthma Preventive Product Picture Figure 2. Global Asthma Preventive Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Asthma Preventive Market Size 2017-2028 (US$ Million) Figure 4. Global Asthma Preventive Sales 2017-2028 (K Units) Figure 5. United States Asthma Preventive Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Asthma Preventive Market Size 2017-2028 (US$ Million) Figure 7. United States Asthma Preventive Sales 2017-2028 (K Units) Figure 8. United States Asthma Preventive Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Asthma Preventive Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Asthma Preventive Report Years Considered Figure 11. Product Picture of Sodium Cromolyn Figure 12. Product Picture of Prednisolone Figure 13. Global Asthma Preventive Market Share by Type in 2022 & 2028 Figure 14. Global Asthma Preventive Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global Asthma Preventive Sales Market Share in Value by Type (2017-2028) Figure 16. Global Asthma Preventive Sales by Type (2017-2028) & (K Units) Figure 17. Global Asthma Preventive Sales Market Share in Volume by Type (2017-2028) Figure 18. Global Asthma Preventive Price by Type (2017-2028) & (USD/Unit) Figure 19. United States Asthma Preventive Market Share by Type in 2022 & 2028 Figure 20. United States Asthma Preventive Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States Asthma Preventive Sales Market Share in Value by Type (2017-2028) Figure 22. United States Asthma Preventive Sales by Type (2017-2028) & (K Units) Figure 23. United States Asthma Preventive Sales Market Share in Volume by Type (2017-2028) Figure 24. United States Asthma Preventive Price by Type (2017-2028) & (USD/Unit) Figure 25. Product Picture of Children Figure 26. Product Picture of Adult Figure 27. Global Asthma Preventive Market Share by Application in 2022 & 2028 Figure 28. Global Asthma Preventive Sales in Value by Application (2017-2028) & (US$ Million) Figure 29. Global Asthma Preventive Sales Market Share in Value by Application (2017-2028) Figure 30. Global Asthma Preventive Sales by Application (2017-2028) & (K Units) Figure 31. Global Asthma Preventive Sales Market Share in Volume by Application (2017-2028) Figure 32. Global Asthma Preventive Price by Application (2017-2028) & (USD/Unit) Figure 33. United States Asthma Preventive Market Share by Application in 2022 & 2028 Figure 34. United States Asthma Preventive Sales in Value by Application (2017-2028) & (US$ Million) Figure 35. United States Asthma Preventive Sales Market Share in Value by Application (2017-2028) Figure 36. United States Asthma Preventive Sales by Application (2017-2028) & (K Units) Figure 37. United States Asthma Preventive Sales Market Share in Volume by Application (2017-2028) Figure 38. United States Asthma Preventive Price by Application (2017-2028) & (USD/Unit) Figure 39. North America Asthma Preventive Sales in Volume Growth Rate 2017-2028 (K Units) Figure 40. North America Asthma Preventive Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 41. U.S. Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 42. Canada Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 43. Europe Asthma Preventive Sales in Volume Growth Rate 2017-2028 (K Units) Figure 44. Europe Asthma Preventive Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 45. Germany Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 46. France Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. U.K. Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. Italy Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Russia Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Asia-Pacific Asthma Preventive Sales in Volume Growth Rate 2017-2028 (K Units) Figure 51. Asia-Pacific Asthma Preventive Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 52. China Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. Japan Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. South Korea Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. India Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. Australia Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. Taiwan Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Indonesia Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Thailand Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Malaysia Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Philippines Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Latin America Asthma Preventive Sales in Volume Growth Rate 2017-2028 (K Units) Figure 63. Latin America Asthma Preventive Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 64. Mexico Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Brazil Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Argentina Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Middle East & Africa Asthma Preventive Sales in Volume Growth Rate 2017-2028 (K Units) Figure 68. Middle East & Africa Asthma Preventive Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 69. Turkey Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Saudi Arabia Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. U.A.E Asthma Preventive Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Asthma Preventive Value Chain Figure 73. Asthma Preventive Production Process Figure 74. Channels of Distribution Figure 75. Distributors Profiles Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Pfizer Abbot Novartis Roche GSK Merck Astrazeneca Biotest AG Boehringer Ingelheim Chiesi Sumitomo Dainippon Pharma Amgen